lithium has been researched along with rivastigmine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clotet, B; Díez-Quevedo, C; Ferrer, MJ; Fumaz, CR; Garolera, M; Miranda, C; Moltó, J; Muñoz-Moreno, JA; Pérez-Álvarez, N; Prats, A | 1 |
| Majidazar, R; Naseri, A; Rezazadeh-Gavgani, E; Sadigh-Eteghad, S | 1 |
1 review(s) available for lithium and rivastigmine
| Article | Year |
|---|---|
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
Topics: Alzheimer Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Glycogen Synthase Kinase 3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indans; Lithium; Melatonin; Memantine; Neurodegenerative Diseases; Rivastigmine; Systematic Reviews as Topic | 2022 |
1 trial(s) available for lithium and rivastigmine
| Article | Year |
|---|---|
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.
Topics: Administration, Cutaneous; Adult; Anti-Retroviral Agents; Cognitive Dysfunction; Executive Function; Female; HIV Infections; Humans; Lithium; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Pilot Projects; Rivastigmine; Treatment Outcome | 2017 |